Expanding treatment options for neuroendocrine tumor patientsHow theranostics changed this patient’s care

Can nuclear medicine and oncology teams provide neuroendocrine tumor patients with more treatment options? The team at Nebraska Cancer Specialists (NCS) says yes—and shows us how.

Glenda, one of the NCS team’s patients, shares her neuroendocrine cancer journey with theranostics. Stories like Glenda’s provide practical insights for cancer centers looking to create or expand their own theranostics programs. In these videos, you can gain a better understanding of the real impact of this approach and what it means to an individual cancer patient.